Study of tear osmolarity and Quality of Life on patients treated with unpreserved latanoprost 0.005%

Trial Profile

Study of tear osmolarity and Quality of Life on patients treated with unpreserved latanoprost 0.005%

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Jul 2017

At a glance

  • Drugs Latanoprost (Primary)
  • Indications Ocular hypertension; Open-angle glaucoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Jul 2017 Status changed from recruiting to completed.
    • 26 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top